Guobo Fang

Title: Guobo Fang: Innovator in Biopharmaceuticals

Introduction

Guobo Fang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of fusion proteins that have therapeutic applications.

Latest Patents

Guobo Fang holds a patent for a fusion protein inhibiting TACI-BAFF complex formation and its preparation method. This invention provides a fusion protein that exhibits high biological activity for blocking BAFF/APPRIL. It has been shown to significantly lower serum IgM concentrations in normal Balb/c mice, as well as serum IgM and IgE concentrations in C57/B6 mice with asthma. The TACI-Fc fusion protein can be utilized in the treatment of autoimmune diseases, including asthma, systemic lupus erythematosus, and rheumatoid arthritis. Additionally, it may be effective in treating B cell enrichment-related diseases such as multiple myeloma, chronic lymphocytic leukemia, macroglobulinemia, and plasmacytic leukemia.

Career Highlights

Throughout his career, Guobo Fang has worked with various companies, including Shanghai Kanda Biotechnology Co., Ltd. and Shanghai Celgen Bio-pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in biopharmaceutical research and development.

Collaborations

Guobo Fang has collaborated with notable professionals in his field, including Zeling Cai and Yi Chen. These collaborations have likely enhanced the impact of his research and innovations.

Conclusion

Guobo Fang is a distinguished inventor whose work in biopharmaceuticals has the potential to significantly impact the treatment of various diseases. His innovative approaches and patented technologies are paving the way for advancements in medical science.